Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
OMIM | RCV000170524 | SCV000223089 | pathogenic | Stromme syndrome | 2015-03-01 | no assertion criteria provided | literature only | |
Prevention |
RCV004752769 | SCV005351091 | pathogenic | CENPF-related disorder | 2024-09-17 | no assertion criteria provided | clinical testing | The CENPF c.574-2A>C variant is predicted to disrupt the AG splice acceptor site and interfere with normal splicing. This variant has been reported in the compound heterozygous state in four siblings with a ciliopathy-like presentation (Figure S3, Waters et al. 2015. PubMed ID: 25564561). This variant has not been reported in a large population database, indicating this variant is rare. Variants that disrupt the consensus splice acceptor site in CENPF are expected to be pathogenic. This variant is interpreted as pathogenic. |